Ketorolac (systemic) vs ACE Inhibitors

Interacting Drugs
Ketorolac (systemic)
vs
ACE Inhibitors
Security Level
Minor, Monitor Therapy
Mechanism
ACE Inhibitors: May enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents. Specifically, the combination may result in a significant decrease in renal function. Nonsteroidal Anti-Inflammatory Agents may diminish the antihypertensive effect of ACE Inhibitors.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Ketorolac (systemic) vs ACE Inhibitors